-
Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapy
Valk, A. M., Koers, J., Derksen, N. I. L., Hogenboom, L., van Kempen, Z., Killestein, J., Rutgers, A., Heeringa, P., Horváth, B., Kuijpers, T. W., van Ham, S. M., Brinke, A. T., van der Woude, D., Toes, R. E. M., Bos, N. A., Rispens, T., Bos, A., Kummer, L. Y., Wieske, L. & Koning, M. & 5 others, , 1 Dec 2025, In: Scientific reports. 15, 1, 14770.Research output: Contribution to journal › Article* › Academic › peer-review
-
A personalized approach for anti-CD20 therapies in multiple sclerosis
Hogenboom, L., van Kempen, Z. L. E., Kalincik, T., Bar-Or, A. & Killestein, J., 1 Nov 2024, In: Multiple sclerosis and related disorders. 91, 105851.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis
Coerver, E., Schoof, L., Hogenboom, L., Wessels, M., van Ruyven, P., van Samkar, A., Mostert, J., van Kempen, Z., van Oosten, B. W., Wokke, B. H., Tallantyre, E., Myhr, K. M., Torkildsen, O., Killestein, J., Smets, I. & Strijbis, E., 1 Nov 2024, In: Multiple Sclerosis and Related Disorders. 91, 105900.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
